CUI JINGRONG JEAN (Chief Scientific Officer) sold 1.5% of their position (11.50K shares) of TURNING POINT THERAPEUTICS, INC. on the open market
Open‑market sale worth $711.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 2/14/2020ACC: 0001209191-20-009652
DirectorOfficer10% Owner· Chief Scientific Officer
Since Apr 2019
-11.50K
Net shares
Net seller
$711.1K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
11.50K disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
−200.00
Price / share
$59.83
Trade value
$11.97K
% of position
0.0%
2/13/2020
792.72K→792.52K
Common Stock
Indirect
Shares
−2.40K
Price / share
$60.70
Trade value
$145.68K
% of position
0.3%
2/13/2020
792.52K→790.12K
Common Stock
Indirect
Shares
−8.80K
Price / share
$62.18
Trade value
$547.18K
% of position
1.1%
2/13/2020
790.12K→781.32K
Common Stock
Indirect
Shares
−100.00
Price / share
$63.07
Trade value
$6.31K
% of position
0.0%
2/13/2020
781.32K→781.22K
Total
Net shares
−11.50K
Net value
-$711.14K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/13/2020 | S · Sale | −200.00 | $59.83 | $11.97K | 0.0% | 792.72K | 792.52K |
| Common Stock Indirect | 2/13/2020 | S · Sale | −2.40K | $60.70 | $145.68K | 0.3% | 792.52K | 790.12K |
| Common Stock Indirect | 2/13/2020 | S · Sale | −8.80K | $62.18 | $547.18K | 1.1% | 790.12K | 781.32K |
| Common Stock Indirect | 2/13/2020 | S · Sale | −100.00 | $63.07 | $6.31K | 0.0% | 781.32K | 781.22K |
| Total | −11.50K | -$711.14K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned1.30M
Total
1.30M direct1.30M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.30M | Direct |
| Total | 1.30M | 1.30M direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported